patients with recurrent acute myelogenous leukemia after transplantation

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With Recurrent Acute Myelogenous Leukemia After Transplantation Trial in Suzhou (CD47 mAb)

Recruiting
  • Patients With Recurrent Acute Myelogenous Leukemia After Transplantation
  • CD47 monoclonal antibody
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Mar 3, 2022